Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Moccia

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
European Journal of Neurology|April 28, 2015
The Framingham cardiovascular risk score in multiple sclerosisM Moccia, R Lanzillo, R Palladino, et al.
European Journal of Neurology|March 6, 2015
Increased bilirubin levels in de novo Parkinson's diseaseM Moccia, M Picillo, R Erro, et al.
European Journal of Neurology|August 14, 2018
Retinal vascular density in multiple sclerosis: a 1-year follow-upR Lanzillo, G Cennamo, M Moccia, et al.
Annals of Medicine|December 11, 2024
Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre studyI Gentile, G Viceconte, F Cuccurullo, et al.
AJNR. American Journal of Neuroradiology|March 2, 2023
MR Imaging Signs of Gadolinium Retention Are Not Associated with Long-Term Motor and Cognitive Outcomes in Multiple SclerosisA Scaravilli, M Tranfa, G Pontillo, et al.
European Journal of Neurology|April 5, 2013
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's diseaseM T Pellecchia, G Santangelo, M Picillo, et al.
European Journal of Neurology|May 23, 2014
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal studyG Santangelo, C Vitale, L Trojano, et al.
European Journal of Neurology|December 17, 2016
Growth hormone/IGF-1 axis longitudinal evaluation in clinically isolated syndrome patients on interferon β-1b therapy: stimulation tests and correlations with clinical and radiological conversion to multiple sclerosisR Lanzillo, C Di Somma, M Quarantelli, et al.
Multiple Sclerosis and Related Disorders|August 11, 2018
Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple SclerosisL Lavorgna, M De Stefano, M Sparaco, et al.
Multiple Sclerosis and Related Disorders|December 2, 2019
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre studyR Lanzillo, M Moccia, R Palladino, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
European Journal of Neurology|April 28, 2015
The Framingham cardiovascular risk score in multiple sclerosisM Moccia, R Lanzillo, R Palladino, et al.
European Journal of Neurology|March 6, 2015
Increased bilirubin levels in de novo Parkinson's diseaseM Moccia, M Picillo, R Erro, et al.
European Journal of Neurology|August 14, 2018
Retinal vascular density in multiple sclerosis: a 1-year follow-upR Lanzillo, G Cennamo, M Moccia, et al.
Annals of Medicine|December 11, 2024
Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre studyI Gentile, G Viceconte, F Cuccurullo, et al.
AJNR. American Journal of Neuroradiology|March 2, 2023
MR Imaging Signs of Gadolinium Retention Are Not Associated with Long-Term Motor and Cognitive Outcomes in Multiple SclerosisA Scaravilli, M Tranfa, G Pontillo, et al.
European Journal of Neurology|April 5, 2013
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's diseaseM T Pellecchia, G Santangelo, M Picillo, et al.
European Journal of Neurology|May 23, 2014
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal studyG Santangelo, C Vitale, L Trojano, et al.
European Journal of Neurology|December 17, 2016
Growth hormone/IGF-1 axis longitudinal evaluation in clinically isolated syndrome patients on interferon β-1b therapy: stimulation tests and correlations with clinical and radiological conversion to multiple sclerosisR Lanzillo, C Di Somma, M Quarantelli, et al.
Multiple Sclerosis and Related Disorders|August 11, 2018
Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple SclerosisL Lavorgna, M De Stefano, M Sparaco, et al.
Multiple Sclerosis and Related Disorders|December 2, 2019
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre studyR Lanzillo, M Moccia, R Palladino, et al.
Pageof 4